MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy

MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy

Saved in:

Bibliographic Details
Main Authors:	Yi Xiao, Jianfeng Zhou, Wei Zhang, Jin Wang, Li Yang, Na Wang, Liang Huang, Jue Wang, Liting Chen, Min Xiao, Jiachen Wang, Zhen Shang, Jinhuan Xu, Weigang Li, Yuqi Guan, Kefeng Shen, Meilan Zhang, Qinlu Li, Cheng He
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-06-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/9/6/e002029.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment
by: Aditi Singh, et al.
Published: (2022-02-01)

Emergence of IGH::CCND1 rearrangement and mutations in TP53, BTK, and BCL2 associated with therapy resistance in chronic lymphocytic leukemia
by: Qing Wei, et al.
Published: (2024-12-01)

Cutaneous manifestations as the presenting signs of diffuse large B-cell lymphoma/high-grade B-cell lymphoma with MYC and BCL2 rearrangements
by: Gabriela Piñero-Crespo, BS, et al.
Published: (2025-01-01)

Terminal deoxynucleotidyl transferase‐positive high‐grade B‐cell lymphoma with MYC and BCL2 rearrangements transformed from follicular lymphoma
by: Radu Chiriac, et al.
Published: (2024-12-01)

The Expression of Bcl-2 and BID in Gastric Cancer Cells
by: Mariusz Gryko, et al.
Published: (2014-01-01)

Hypoxic stress caused apoptosis of MDBK cells by p53/BCL6-mitochondrial apoptosis pathway
by: Bin Li, et al.
Published: (2024-12-01)

Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function
by: Atenea A. Perez-Serna, et al.
Published: (2025-01-01)

Functions of BCL-XL at the Interface between Cell Death and Metabolism
by: Judith Michels, et al.
Published: (2013-01-01)

Evaluation of the clinical efficacy of modified LSC transplantation plus BCL implantation in the treatment of pterygium
by: Ying Li, et al.
Published: (2024-12-01)

PCNA, Ki-67, p53, bcl-2 and Prognosis in Intraoral Squamous Cell Carcinoma of the Head and Neck
by: Karin Nylander, et al.
Published: (1997-01-01)

Quantifying the inhibitory effect of Bcl‐xl on the action of Mff using live‐cell fluorescence imaging
by: Yunyun Ma, et al.
Published: (2019-12-01)

Double-Hit Primary Plasma Cell Leukemia with IGH/MYC and IGH/CCND1 Translocations
by: Masato Yasumi, et al.
Published: (2020-01-01)

RETRACTED: MicroRNA‐498 reduces the proliferation and invasion of colorectal cancer cells via targeting Bcl‐2
by: Tongsheng Wang, et al.
Published: (2020-01-01)

BCL-2 overexpression exosomes promote the proliferation and migration of mesenchymal stem cells in hypoxic environment for skin injury in rats
by: Ying Wang, et al.
Published: (2025-01-01)

Gallbladder Carcinomas: An Immunoprognostic Evaluation of P53; Bcl-2; CEA and Alpha-Fetoprotein
by: R Kanthan, et al.
Published: (2000-01-01)

Tumorigenicity decrease in Bcl-xL deficient MDCK cells ensuring the safety for influenza vaccine production
by: Jiahao Zheng, et al.
Published: (2024-01-01)

BCL6 (B-cell lymphoma 6) expression in adenomyosis, leiomyomas and normal myometrium.
by: Loreta Canivilo Salas, et al.
Published: (2025-01-01)

Analyzing inhibition of BCL11A gene expression in K562 cells by RNAi
by: Vikas Urkude
Published: (2014-08-01)

Developing and Activated T Cell Survival Depends on Differential Signaling Pathways to Regulate Anti-Apoptotic Bcl-xL
by: Ruiqing Wang, et al.
Published: (2012-01-01)

Targeting the IKZF1/BCL-2 axis as a novel therapeutic strategy for treating acute T-cell lymphoblastic leukemia
by: Juan Li, et al.
Published: (2025-12-01)

The Super Anti-Apoptotic Factor Bcl-xFNK: A Novel Mutant of Rat Bcl-Xl with a Gain-of-Function Phenotype
by: Sadamitsu Asoh, et al.
Published: (2001-01-01)

An Efficient Method for Immortalizing Mouse Embryonic Fibroblasts by CRISPR-mediated Deletion of the Tp53 Gene
by: Srisathya Srinivasan, et al.
Published: (2025-01-01)

BCL-2 AND IAP Proteins As Potential Drug Targets
by: Stephen W. Fesik
Published: (2001-01-01)

Retraction: Mutual Regulation of Bcl-2 Proteins Independent of the BH3 Domain as Shown by the BH3-Lacking Protein Bcl-xAK.
by: PLOS ONE Editors
Published: (2024-01-01)

Downregulation of Bcl-2 Expression by miR-34a Mediates Palmitate-Induced Min6 Cells Apoptosis
by: Xiaojie Lin, et al.
Published: (2014-01-01)

PSTK exerts protective role in cisplatin‐tubular cell injury via BAX/BCL2/Caspase3 pathway
by: Yifan Wu, et al.
Published: (2025-01-01)

Synchronous Occurrence of Splenic Pleomorphic Mantle Cell Lymphoma and Esophageal Adenocarcinoma with Overexpression of BCL1 Protein
by: Dominik Dabrowski, et al.
Published: (2020-01-01)

Bcl-2 and galectin-3 expression is associated with recurrence of ameloblastoma
Published: (2024-12-01)

Altered Expression of Cellular Bcl-2 in the Progression of Hamster Cholangiocarcinogenesis
by: Byung-suk Jeon, et al.
Published: (2012-01-01)

BCL2i-Based Therapies and Emerging Resistance in Chronic Lymphocytic Leukemia
by: Wing Fai Li, et al.
Published: (2024-11-01)

p-AXL与c-MYC和/或BCL-2共表达在弥漫大B细胞性淋巴瘤中的临床意义
by: 缪娜波, et al.
Published: (2020-07-01)

Ganoderma lucidum Polysaccharide (GLP) Inhibited the Progression of Oral Squamous Cell Carcinoma via the miR-188/BCL9/β-Catenin Pathway
by: Zhigang Zeng, et al.
Published: (2020-01-01)

Aptamer sgc8-Modified PAMAM Nanoparticles for Targeted siRNA Delivery to Inhibit BCL11B in T-Cell Acute Lymphoblastic Leukemia
by: Zeng X, et al.
Published: (2024-11-01)

Bcl2 Family Functions as Signaling Target in Nicotine-/NNK-Induced Survival of Human Lung Cancer Cells
by: Xingming Deng
Published: (2014-01-01)

Predictive value of TP53 RNAscope® in situ hybridization and p53 immunohistochemistry for TP53 mutational status in canine diffuse large B-cell lymphoma
by: Greta Foiani, et al.
Published: (2024-12-01)

Acquired BCL2 variants associated with venetoclax resistance in acute myeloid leukemia
by: Fiona C. Brown, et al.
Published: (2025-01-01)

Impact of TP53 mutations on the efficacy of CAR-T cell therapy in cancer
by: Regina Mirgayazova, et al.
Published: (2024-12-01)

Bcl-2 expression and image analysis of premalignant and malignant colonic lesions
by: Sonia L. El-Sharkawy, et al.
Published: (2024-01-01)

Clinicopathological correlation of Bcl-2 oncoprotein expression in oral precancer and cancer
by: Vandana Arya, et al.
Published: (2016-01-01)

The Role of Bcl-2 Family Proteins and Sorafenib Resistance in Hepatocellular Carcinoma
by: Alex José de Melo Silva, et al.
Published: (2024-01-01)